Singapore: WuXi PharmaTech, a China-based contract research organization (CRO), has obtained a multiyear license to Adme...
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...
Nemus Bioscience Inc. has announced that the pro-drug of tetrahydrocannabinol (THC) in-licensed from the company's resea...
Singapore: Chinese Food and Drug Administration (CFDA) has approved Israel based D-Pharm to conduct clinical development...
Singapore: In a move to accelerate genome sequencing and bring breakthrough in cancer treatment in the country, UK has...
Tokyo's Mochida Pharmaceutical Co. Ltd. has filed for a new drug application (NDA) for MD-0901 with the Japanese Ministr...
Singapore: Sanofi has terminated NaP2b inhibitors development deal with US based Ardelyx, a clinical-stage biopharmaceut...
Singapore: Global technology firm AB SCIEX and Dalton Pharma Services have formed a research collaboration to develop An...
Singapore: Global experts have commented that the lack of adequate funding was a major drawback that discouraged researc...
Singapore: Australia based drug discovery company, Viralytics, has recieved UK Medicines and Healthcare Products Regulat...
Singapore: Clinical research firm, AMRI, has received a 10-year federal contract award from the National Institutes of H...
Singapore: Singapore start-up and Scotland based TauRx Therapeutics is progressing in its two Phase III clinical trials ...
Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209...
Singapore: Taiwan based Genovate Biotechnology and ScinoPharm have jointly developed the highly potent oral generic drug...
Singapore: Global biopharmaceutical company, Roche, has acquired InterMune, a biotechnology company focused on the resea...
Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...
Tokyo: Japan's Daiichi Sankyo Company Limited has announced details of the application for its Take a New Challenge for ...
Singapore: Australia biotech firm, Prescient Therapeutics, a clinical stage oncology company, has secured agreement from...
